Literature DB >> 11526242

An anti-angiogenic state in mice and humans with retinal photoreceptor cell degeneration.

J Lahdenranta1, R Pasqualini, R O Schlingemann, M Hagedorn, W B Stallcup, C D Bucana, R L Sidman, W Arap.   

Abstract

Abnormal angiogenesis accompanies many pathological conditions including cancer, inflammation, and eye diseases. Proliferative retinopathy because of retinal neovascularization is a leading cause of blindness in developed countries. Another major cause of irreversible vision loss is retinitis pigmentosa, a group of diseases characterized by progressive photoreceptor cell degeneration. Interestingly, anecdotal evidence has long suggested that proliferative diabetic retinopathy is rarely associated clinically with retinitis pigmentosa. Here we show that neonatal mice with classic inherited retinal degeneration (Pdeb(rd1)/Pdeb(rd1)) fail to mount reactive retinal neovascularization in a mouse model of oxygen-induced proliferative retinopathy. We also present a comparable human paradigm: spontaneous regression of retinal neovascularization associated with long-standing diabetes mellitus occurs when retinitis pigmentosa becomes clinically evident. Both mouse and human data indicate that reactive retinal neovascularization either fails to develop or regresses when the number of photoreceptor cells is markedly reduced. Our findings support the hypothesis that a functional mechanism underlying this anti-angiogenic state is failure of the predicted up-regulation of vascular endothelial growth factor, although other growth factors may also be involved. Preventive and therapeutic strategies against both proliferative and degenerative retinopathies may emerge from this work.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11526242      PMCID: PMC56967          DOI: 10.1073/pnas.181329198

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  48 in total

1.  The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor.

Authors:  S Basu; J A Nagy; S Pal; E Vasile; I A Eckelhoefer; V S Bliss; E J Manseau; P S Dasgupta; H F Dvorak; D Mukhopadhyay
Journal:  Nat Med       Date:  2001-05       Impact factor: 53.440

2.  Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.

Authors:  P Carmeliet; L Moons; A Luttun; V Vincenti; V Compernolle; M De Mol; Y Wu; F Bono; L Devy; H Beck; D Scholz; T Acker; T DiPalma; M Dewerchin; A Noel; I Stalmans; A Barra; S Blacher; T VandenDriessche; A Ponten; U Eriksson; K H Plate; J M Foidart; W Schaper; D S Charnock-Jones; D J Hicklin; J M Herbert; D Collen; M G Persico
Journal:  Nat Med       Date:  2001-05       Impact factor: 53.440

3.  Role of the pigment epithelium in inherited retinal degeneration analyzed with experimental mouse chimeras.

Authors:  M M LaVail; R J Mullen
Journal:  Exp Eye Res       Date:  1976-08       Impact factor: 3.467

4.  Retinal hemodynamics in retinitis pigmentosa.

Authors:  J E Grunwald; A M Maguire; J Dupont
Journal:  Am J Ophthalmol       Date:  1996-10       Impact factor: 5.258

5.  Pigment epithelium-derived factor: a potent inhibitor of angiogenesis.

Authors:  D W Dawson; O V Volpert; P Gillis; S E Crawford; H Xu; W Benedict; N P Bouck
Journal:  Science       Date:  1999-07-09       Impact factor: 47.728

6.  Discrimination of light intensity by rats with inherited retinal degeneration: a behavioral and cytological study.

Authors:  M M LaVail; M Sidman; R Rausin; R L Sidman
Journal:  Vision Res       Date:  1974-08       Impact factor: 1.886

7.  Differential effect of the rd mutation on rods and cones in the mouse retina.

Authors:  L D Carter-Dawson; M M LaVail; R L Sidman
Journal:  Invest Ophthalmol Vis Sci       Date:  1978-06       Impact factor: 4.799

8.  Clinical features of autosomal dominant retinitis pigmentosa with rhodopsin gene codon 17 mutation and retinal neovascularization in a Japanese patient.

Authors:  M Hayakawa; Y Hotta; Y Imai; K Fujiki; A Nakamura; K Yanashima; A Kanai
Journal:  Am J Ophthalmol       Date:  1993-02-15       Impact factor: 5.258

9.  Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal.

Authors:  L E Benjamin; D Golijanin; A Itin; D Pode; E Keshet
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

10.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

Authors:  L P Aiello; R L Avery; P G Arrigg; B A Keyt; H D Jampel; S T Shah; L R Pasquale; H Thieme; M A Iwamoto; J E Park
Journal:  N Engl J Med       Date:  1994-12-01       Impact factor: 91.245

View more
  32 in total

Review 1.  The mouse retina as an angiogenesis model.

Authors:  Andreas Stahl; Kip M Connor; Przemyslaw Sapieha; Jing Chen; Roberta J Dennison; Nathan M Krah; Molly R Seaward; Keirnan L Willett; Christopher M Aderman; Karen I Guerin; Jing Hua; Chatarina Löfqvist; Ann Hellström; Lois E H Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06       Impact factor: 4.799

Review 2.  The pathogenesis of early retinal changes of diabetic retinopathy.

Authors:  G B Arden; S Sivaprasad
Journal:  Doc Ophthalmol       Date:  2012-02       Impact factor: 2.379

3.  Lutein facilitates physiological revascularization in a mouse model of retinopathy of prematurity.

Authors:  Zhongjie Fu; Steven S Meng; Samuel B Burnim; Lois Eh Smith; Amy Cy Lo
Journal:  Clin Exp Ophthalmol       Date:  2017-01-29       Impact factor: 4.207

4.  The peptidomimetic Vasotide targets two retinal VEGF receptors and reduces pathological angiogenesis in murine and nonhuman primate models of retinal disease.

Authors:  Richard L Sidman; Jianxue Li; Matthew Lawrence; Wenzheng Hu; Gary F Musso; Ricardo J Giordano; Marina Cardó-Vila; Renata Pasqualini; Wadih Arap
Journal:  Sci Transl Med       Date:  2015-10-14       Impact factor: 17.956

Review 5.  Spare the rod and spoil the eye.

Authors:  G B Arden; R L Sidman; W Arap; R O Schlingemann
Journal:  Br J Ophthalmol       Date:  2005-06       Impact factor: 4.638

6.  PGC-1α regulates normal and pathological angiogenesis in the retina.

Authors:  Magali Saint-Geniez; Aihua Jiang; Stephanie Abend; Laura Liu; Harry Sweigard; Kip M Connor; Zoltan Arany
Journal:  Am J Pathol       Date:  2012-11-07       Impact factor: 4.307

7.  Rapid and Integrative Discovery of Retina Regulatory Molecules.

Authors:  Nicholas E Albrecht; Jonathan Alevy; Danye Jiang; Courtney A Burger; Brian I Liu; Fenge Li; Julia Wang; Seon-Young Kim; Chih-Wei Hsu; Sowmya Kalaga; Uchechukwu Udensi; Chinwe Asomugha; Ritu Bohat; Angelina Gaspero; Monica J Justice; Peter D Westenskow; Shinya Yamamoto; John R Seavitt; Arthur L Beaudet; Mary E Dickinson; Melanie A Samuel
Journal:  Cell Rep       Date:  2018-08-28       Impact factor: 9.423

8.  Active HIF-1 in the normal human retina.

Authors:  John M Hughes; Arjan J Groot; Petra van der Groep; René Sersansie; Marc Vooijs; Paul J van Diest; Cornelis J F Van Noorden; Reinier O Schlingemann; Ingeborg Klaassen
Journal:  J Histochem Cytochem       Date:  2009-11-09       Impact factor: 2.479

9.  Intravitreal pegaptanib sodium (Macugen) for refractory cystoid macular edema in pericentral retinitis pigmentosa.

Authors:  Giuseppe Querques; Francesco Prascina; Cristiana Iaculli; Nicola Delle Noci
Journal:  Int Ophthalmol       Date:  2007-12-22       Impact factor: 2.031

10.  Retinal neovascularization induced by mutant Vldlr gene inhibited in an inherited retinitis pigmentosa mouse model: an in-vivo study.

Authors:  Wei-Ming Yan; Pan Long; Mei-Zhu Chen; Dong-Yu Wei; Jian-Cong Wang; Zuo-Ming Zhang; Lei Zhang; Tao Chen
Journal:  Int J Ophthalmol       Date:  2021-07-18       Impact factor: 1.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.